Skip to main content

Table 3 Procedural data

From: Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis.

  Overall
(N = 180)
TA-TAVI (N = 90) TF-TAVI (N = 90) p
Sapien™ and Sapien XT™ 146 (81%) 86 (96%) 60 (67%)  
Sapien 3™ 8 (4%) 4 (4%) 4 (4%)  
CoreValve™ 26 (29%) NA 26 (29%)  
Valve-in-valve in degenerated bioprosthesis 12 (7%) 7 (8%) 5 (6%) 0.550a
Bailout valve-in-valve for migration or malpositioning 7 (4%) 3 (3%) 4 (4%) 1
Mean valve size (mm) 25 ± 2.1 25 ± 1.9 25 ± 2.2  
Valve size distribution
 23 mm 75 (42%) 40 (44%) 35 (39%)  
 26 mm 77 (43%) 43 (48%) 44 (49%)  
 29 mm 14 (8%) 7 (8%) 7 (8%)  
 31 mm 4 (4%) 0 (0%) 4 (4%)  
Procedural time (min) 113 ± 48 98 ± 33 127 ± 56 <0.001
  1. Data presented as mean ± SD or N (%)
  2. a Chi2 value, otherwise it’s a Fischer test or a T-Test value